Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia.
Saved in:
| Title: | Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. |
|---|---|
| Authors: | Yang, Tingting1,2,3 (AUTHOR) 21818093@zju.edu.cn, Dong, Yetian1,2,3 (AUTHOR) 937152718@qq.com, Zhang, Mingming1,2,3 (AUTHOR) mingmingzhang@zju.edu.cn, Feng, Jingjing1,2,3 (AUTHOR) elinafengjj@foxmail.com, Fu, Shan1,2,3 (AUTHOR) fushan@zju.edu.cn, Xiao, Pingnan1,2,3 (AUTHOR) pingnanxiao@126.com, Hong, Ruimin1,2,3 (AUTHOR) hongrm0327@163.com, Xu, Huijun1,2,3 (AUTHOR) xuhuijunha@foxmail.com, Cui, Jiazhen1,2,3 (AUTHOR) cuijiazhen2008@126.com, Huang, Simao1,2,3 (AUTHOR) huangsimao2022@163.com, Wei, Guoqing1,2,3 (AUTHOR) weiguoqing2000@sina.com, Kong, Delin1,2,3 (AUTHOR) Kongdl@zju.edu.cn, Geng, Jia4 (AUTHOR) gj_1217@163.com, Chang, Alex H.5,6 (AUTHOR) changah@yakebiotech.com, Huang, He1,2,3 (AUTHOR) huanghe@zju.edu.cn, Hu, Yongxian1,2,3 (AUTHOR) 1313016@zju.edu.cn |
| Source: | Experimental Hematology & Oncology. 1/3/2025, Vol. 14 Issue 1, p1-11. 11p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: asn DbLabel: Academic Search Ultimate An: 182076029 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Yang%2C+Tingting%22">Yang, Tingting</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> 21818093@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Dong%2C+Yetian%22">Dong, Yetian</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> 937152718@qq.com</i><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Mingming%22">Zhang, Mingming</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> mingmingzhang@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Feng%2C+Jingjing%22">Feng, Jingjing</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> elinafengjj@foxmail.com</i><br /><searchLink fieldCode="AR" term="%22Fu%2C+Shan%22">Fu, Shan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> fushan@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Xiao%2C+Pingnan%22">Xiao, Pingnan</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> pingnanxiao@126.com</i><br /><searchLink fieldCode="AR" term="%22Hong%2C+Ruimin%22">Hong, Ruimin</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> hongrm0327@163.com</i><br /><searchLink fieldCode="AR" term="%22Xu%2C+Huijun%22">Xu, Huijun</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> xuhuijunha@foxmail.com</i><br /><searchLink fieldCode="AR" term="%22Cui%2C+Jiazhen%22">Cui, Jiazhen</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> cuijiazhen2008@126.com</i><br /><searchLink fieldCode="AR" term="%22Huang%2C+Simao%22">Huang, Simao</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> huangsimao2022@163.com</i><br /><searchLink fieldCode="AR" term="%22Wei%2C+Guoqing%22">Wei, Guoqing</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> weiguoqing2000@sina.com</i><br /><searchLink fieldCode="AR" term="%22Kong%2C+Delin%22">Kong, Delin</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> Kongdl@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Geng%2C+Jia%22">Geng, Jia</searchLink><relatesTo>4</relatesTo> (AUTHOR)<i> gj_1217@163.com</i><br /><searchLink fieldCode="AR" term="%22Chang%2C+Alex+H%2E%22">Chang, Alex H.</searchLink><relatesTo>5,6</relatesTo> (AUTHOR)<i> changah@yakebiotech.com</i><br /><searchLink fieldCode="AR" term="%22Huang%2C+He%22">Huang, He</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> huanghe@zju.edu.cn</i><br /><searchLink fieldCode="AR" term="%22Hu%2C+Yongxian%22">Hu, Yongxian</searchLink><relatesTo>1,2,3</relatesTo> (AUTHOR)<i> 1313016@zju.edu.cn</i> – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22Experimental+Hematology+%26+Oncology%22">Experimental Hematology & Oncology</searchLink>. 1/3/2025, Vol. 14 Issue 1, p1-11. 11p. |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=182076029 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s40164-024-00593-5 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 11 StartPage: 1 Titles: – TitleFull: Prominent efficacy and good safety of sequential CD19 and CD22 CAR-T therapy in relapsed/refractory adult B-cell acute lymphoblastic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Yang, Tingting – PersonEntity: Name: NameFull: Dong, Yetian – PersonEntity: Name: NameFull: Zhang, Mingming – PersonEntity: Name: NameFull: Feng, Jingjing – PersonEntity: Name: NameFull: Fu, Shan – PersonEntity: Name: NameFull: Xiao, Pingnan – PersonEntity: Name: NameFull: Hong, Ruimin – PersonEntity: Name: NameFull: Xu, Huijun – PersonEntity: Name: NameFull: Cui, Jiazhen – PersonEntity: Name: NameFull: Huang, Simao – PersonEntity: Name: NameFull: Wei, Guoqing – PersonEntity: Name: NameFull: Kong, Delin – PersonEntity: Name: NameFull: Geng, Jia – PersonEntity: Name: NameFull: Chang, Alex H. – PersonEntity: Name: NameFull: Huang, He – PersonEntity: Name: NameFull: Hu, Yongxian IsPartOfRelationships: – BibEntity: Dates: – D: 03 M: 01 Text: 1/3/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 21623619 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Experimental Hematology & Oncology Type: main |
| ResultId | 1 |